Expert Review of Anti-Infective Therapy

Papers
(The H4-Index of Expert Review of Anti-Infective Therapy is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a98
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex77
Neonatal ocular prophylaxis in the United States: is it still necessary?69
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin63
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future61
Challenges in preserving antibiotic effectiveness: time for a novel approach51
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies46
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials39
Visceral leishmaniasis elimination in India: progress and the road ahead39
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis39
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review39
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR72035
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines34
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria33
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies33
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’28
Identifying predictors of treatment failure with community-acquired pneumonia: an update26
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?26
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis25
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis24
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China23
Reemergence of monkeypox: prevention and management22
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges22
Treatment of vaginitis caused by non-albicans Candida species22
0.23141098022461